Management of diabetes mellitus: Could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea?

International Journal of Molecular Sciences

Volumn 13, Issue 3, 2012, Pages 2965-2972

  Erejuwa, Omotayo O ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Antioxidants; Glycemic control; Hyperglycemia; Hypoglycemic drugs; Intensive therapy; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; C PEPTIDE; GLIBENCLAMIDE; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; METFORMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; GLUCOSE BLOOD LEVEL;

ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC PATIENT; DRUG FATALITY; DYSLIPIDEMIA; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY FUNCTION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; SEDENTARY LIFESTYLE; SIDE EFFECT; WEIGHT GAIN; BLOOD; DIABETES COMPLICATIONS; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM;

ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; OXIDATIVE STRESS; WEIGHT GAIN;

EID: 84858968433     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13032965     Document Type: Article

References (44)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34, S62-S69.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329, 977-986.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352, 837-853.
4. Finfer, S.; Chittock, D.R.; Su, S.Y.; Blair, D.; Foster, D.; Dhingra, V.; Bellomo, R.; Cook, D.; Dodek, P.; Henderson, W.R., et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009, 360, 1283-1297.
5. Gerstein, H.C.; Miller, M.E.; Byington, R.P.; Goff, D.C., Jr.; Bigger, J.T.; Buse, J.B.; Cushman, W.C.; Genuth, S.; Ismail-Beigi, F.; Grimm, R.H., Jr., et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 2008, 358, 2545-2559.
6. Ismail-Beigi, F.; Craven, T.; Banerji, M.A.; Basile, J.; Calles, J.; Cohen, R.M.; Cuddihy, R.; Cushman, W.C.; Genuth, S.; Grimm, R.H., Jr., et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010, 376, 419-430.
7. Turner, R.C.; Cull, C.A.; Frighi, V.; Holman, R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA 1999, 281, 2005-2012.
8. Cook, M.N.; Girman, C.J.; Stein, P.P.; Alexander, C.M.; Holman, R.R. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care 2005, 28, 995-1000.
9. George, B.; Cebioglu, M.; Yeghiazaryan, K. Inadequate diabetic care: Global figures cry for preventive measures and personalizedtreatment. EPMA J. 2010, 1, 13-18.
10. Whiting, D.R.; Guariguata, L.; Weil, C.; Shaw, J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94, 311-321.
11. Cryer, P.E. Death during intensive glycemic therapy of diabetes: Mechanisms and implications. Am. J. Med. 2011, 124, 993-996.
12. Sies, H. Oxidative Stress: Introduction. In Oxidative Stress: Oxidants and Antioxidants; Sies, H., ed.; Academic Press: London, UK, 1991; pp. 15-22.
13. Chang, Y.C.; Chuang, L.M. The role of oxidative stress in the pathogenesis of type 2 diabetes: From molecular mechanism to clinical implication. Am. J. Transl. Res. 2010, 2, 316-331.
14. Giacco, F.; Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 2010, 107, 1058-1070.
15. Wiernsperger, N.F. Oxidative stress as a therapeutic target in diabetes: Revisiting the controversy. Diabetes Metab. 2003, 29, 579-585.
16. Hammes, H.P.; Klinzing, I.; Wiegand, S.; Bretzel, R.G.; Cohen, A.M.; Federlin, K. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest. Ophthalmol. Vis. Sci. 1993, 34, 2092-2096.
17. Kowluru, R.A.; Kanwar, M.; Kennedy, A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp. Diabetes Res. 2007, 2007, doi: 10.1155/2007/21976.
18. Ceriello, A.; Ihnat, M.A.; Thorpe, J.E. Clinical review 2: The "metabolic memory": Is more than just tight glucose control necessary to prevent diabetic complications? J. Clin. Endocrinol. Metab. 2009, 94, 410-415.
19. Nishikawa, T.; Edelstein, D.; Brownlee, M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int. Suppl. 2000, 77, S26-S30.
20. Sindhu, R.K.; Koo, J.R.; Roberts, C.K.; Vaziri, N.D. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: Response to insulin and antioxidant therapies. Clin. Exp. Hypertens. 2004, 26, 43-53.
21. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats. Int. J. Biol. Sci. 2011, 7, 244-252.
22. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Effect of Glibenclamide alone versus glibenclamide and honey on oxidative stress in pancreas of streptozotocin-induced diabetic rats. Int. J. Appl. Res. Nat. Prod. 2011, 4, 1-10.
23. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2010, 11, 2056-2066.
24. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2011, 12, 829-843.
25. Qiang, X.; Satoh, J.; Sagara, M.; Fukuzawa, M.; Masuda, T.; Miyaguchi, S.; Takahashi, K.; Toyota, T. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats. Metabolism 1998, 47, 977-981.
26. Chugh, S.N.; Kakkar, R.; Kalra, S.; Sharma, A. An evaluation of oxidative stress in diabetes mellitus during uncontrolled and controlled state and after vitamin E supplementation. J. Assoc. Physicians India 1999, 47, 380-383.
27. Sharma, A.; Kharb, S.; Chugh, S.N.; Kakkar, R.; Singh, G.P. Effect of glycemic control and vitamin E supplementation on total glutathione content in non-insulin-dependent diabetes mellitus. Ann. Nutr. Metab. 2000, 44, 11-13.
28. Jennings, P.E.; Scott, N.A.; Saniabadi, A.R.; Belch, J.J. Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment. Metabolism 1992, 41, 36-39.
29. Ceriello, A.; Kumar, S.; Piconi, L.; Esposito, K.; Giugliano, D. Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes. Diabetes Care 2007, 30, 649-654.
30. Erejuwa, O.O.; Gurtu, S.; Sulaiman, S.A.; ab Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int. J. Vitam. Nutr. Res. 2010, 80, 74-82.
31. Sargeant, L.A.; Wareham, N.J.; Bingham, S.; Day, N.E.; Luben, R.N.; Oakes, S.; Welch, A.; Khaw, K.T. Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk) study: A population-based study. Diabetes Care 2000, 23, 726-732.
32. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats. Ann. Endocrinol. (Paris) 2010, 71, 291-296.
33. Kajimoto, Y.; Kaneto, H. Role of oxidative stress in pancreatic β-cell dysfunction. Ann. NY Acad. Sci. 2004, 1011, 168-176.
34. Robertson, R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 2004, 279, 42351-42354.
35. Meydani, M. Vitamin E and atherosclerosis: Beyond prevention of LDL oxidation. J. Nutr. 2001, 131, 366S-368S.
36. Rahimi, R.; Nikfar, S.; Larijani, B.; Abdollahi, M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother. 2005, 59, 365-373.
37. Lai, M.H. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and E supplementation for type 2 diabetes mellitus. J. Clin. Biochem. Nutr. 2008, 43, 191-198.
38. Bhor, V.M.; Sivakami, S. Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation. Mol. Cell. Biochem. 2003, 252, 125-132.
39. Faria, A.; Monteiro, R.; Pestana, D.; Freitas, V.; Mateus, N.; Azevedo, I.; Calhau, C. Intestinal oxidative state can alter nutrient and drug bioavailability. Oxid. Med. Cell. Longev. 2009, 2, 322-327.
40. Dias, A.S.; Porawski, M.; Alonso, M.; Marroni, N.; Collado, P.S.; Gonzalez-Gallego, J. Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J. Nutr. 2005, 135, 2299-2304.
41. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Hepatoprotective effect of tualang honey supplementation in streptozotocin-induced diabetic rats. Int. J. Appl. Res. Nat. Prod. 2012, 4, 37-41.
42. Razquin, C.; Martinez, J.A.; Martinez-Gonzalez, M.A.; Mitjavila, M.T.; Estruch, R.; Marti, A. A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain. Eur. J. Clin. Nutr. 2009, 63, 1387-1393.
43. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic wistar-kyoto rats and spontaneously hypertensive rats: effects of antioxidant (honey) treatment. Int. J. Mol. Sci. 2011, 12, 1888-1907.
44. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S.; Sirajudeen, K.N.; Salleh, M.S.; Gurtu, S. Honey supplementation in spontaneously hypertensive rats elicits antihypertensive effect via amelioration of renal oxidative stress. Oxid. Med. Cell. Longev. 2012, 2012, doi:10.1155/2012/374037.